Natco gets emergency use nod for Baricitinib to treat Covid-19

In a statement, the Hyderabad headquartered pharma company said Baricitinib in combination with Remdesivir is used for the treatment of Covid-19 patients.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ufBw91
via IFTTT